News Results for Astrazeneca (AZN)

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8870p (from 8810p). Story provided by StockMarketWire.com Broker Forecasts...

The FTSE 100 had a subdued start, opening 20 points up in early morning trading at 5,461 as the UK continues to take stringent measures in its fight against coronavirus. Italy appeared to...

Pharma giant AstraZeneca said it had completed the previously agreed sale of its global rights to Movantik, a treatment for opioid-induced constipation, to RedHill Biopharma for at least $52.5m....

Oddo today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 7600p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data provided by...

Pascal Soriot, Chief Executive Officer, has transferred in 74,698 shares in the company on the 27th March 2020 at a price of 0.00p. The Director now holds 289,032 shares. NOTE: Vesting Story...

Marc Dunoyer, Financial Director, has transferred in 19,429 shares in the company on the 27th March 2020 at a price of 0.00p. The Director now holds 304,991 shares. NOTE: Vesting Story provided...

Pharma giant AstraZeneca's said it drug to treat extensive-stage small cell lung cancer in combination with chemotherapies had been approved in the US. The approval by the Food and Drug...

Pascal Soriot, Chief Executive Officer, has transferred in 7,338 shares in the company on the 24th March 2020 at a price of 0.00p. The Director now holds 214,334 shares. NOTE: Vesting - net of...

Marc Dunoyer, Financial Director, has transferred in 2,344 shares in the company on the 24th March 2020 at a price of 0.00p. The Director now holds 285,562 shares. NOTE: Vesting - net of shares...

Pharma giant AstraZeneca said its treatment for hyperkalaemia, a disease reflecting elevated levels of potassium in the blood, had been approved in Japan. The approval of the company's drug...

Silence Therapeutics said it had formed a strategic collaboration arrangement with AstraZeneca to develop therapeutics for the treatment of cardiovascular, renal, metabolic and respiratory...

After retreating earlier on Tuesday, FTSE rallied back into positive territory in the afternoon following US markets higher after president Trump unveiled more stimulus measures to tackle the virus...

After opening higher on Tuesday, FTSE retreated into negative territory at midday, as investors continued to question how severely the worsening coronavirus outbreak will hurt the global economy....

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 8000p (from 8500p). Story provided by StockMarketWire.com Broker...

Pharma giant AstraZeneca said its lung cancer drug in combination with chemotherapies confirmed a clinically meaningful improvement in survival rates for patients with extensive-stage small cell...

The FTSE 100 recorded the second biggest one-day fall in its history on Thursday, as investors increasingly look to sell risk assets. The UK's benchmark index closed down a staggering 10.87%, or...

The FTSE 100 continued on its downward trajectory by midday on Thursday, having hit its lowest point in four years when it closed yesterday. At 1200, the index fell 5.7%, losing 334 points to...

The FTSE 100 continued on its downward trajectory in early morning trading, having hit its lowest point in four years when it closed yesterday. The index fell 5.35%, losing 314 points to reach...

Pharma giant AstraZeneca said its trial of a potential new medicine to treat patients with sensitive relapsed ovarian cancer had failed to meet its primary objective of improving survival rates...

It was an absolute bloodbath for UK shares on Friday as growth fears escalated from the spreading coronavirus outbreak, leaving markets staring down the barrel of a second straight week of losses....

UK stocks plunged again on Friday leaving investors braced for a second straight week of losses as growth fears escalate from the spreading coronavirus outbreak. Even the US Fed rate cut earlier in...

UK stocks fell heavily on Friday as the coronavirus continued to spread rapidly around the world, including in the UK and US. At 0813, the benchmark FTSE 100 index was down 98.94 points, or...

Pharmaceutical company AstraZeneca said its trial for a bladder cancer treatment had failed to meet its primary goal. The trial of the 'stage four' treatment had failed to improve patient...

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6000p (from 5800p). Story provided by StockMarketWire.com Broker Forecasts data provided...

UK stocks had a volatile Monday after surging on central bank stimulus hopes, before plummeting on warnings over global growth and then rising again as the World Bank and International Monetary...

A rally in UK stocks this morning was short lived as the Organisation for Economic Co-operation and Development warned the coronavirus outbreak could halve its 2020 global growth forecast. Shares...

UK stocks rebounded on Monday, having undergone a savaging last week, as investors focused on the potential for co-ordinated global stimulus measures to cushion the impact of the coronovirus. At...

AstraZeneca said it had completed the sale of the global commercial rights of its hypertension medicines to Atnahs Pharma for up to $390m. The divestment was previously announced in late-January....

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 8300p (from 8400p). Story provided by StockMarketWire.com Broker Forecasts data...

Pharmaceuticals giant AstraZeneca said it had agreed to sell global rights to a constipation drug excluding Europe, Canada and Israel to RedHill Biopharma for an upfront payment of $52.5m....

Michel Demare, Non Executive Director, bought 700 shares in the company on the 17th February 2020 at a price of 7313.00p. The Director now holds 700 shares representing 0.00% of the shares in...

Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 7700p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data...

UK markets endured a mixed close to the trading week with the FTSE 100 failing to hold on to mid-Friday gains. An unwelcome warning of downward pressure on Royal Bank of Scotland's income and...

UK markets staged a late morning rally to erase earlier declines as investors turned their attention on upcoming fourth-quarter GDP data from across the Eurozone. This was despite Royal Bank of...

UK stocks opened lower on Friday as the coronavirus death toll continued to climb and Royal Bank of Scotland warned of downward pressure on its income. At 0824, the benchmark FTSE 100 index had...

Pharmaceutical company AstraZeneca posted a 22% fall in annual profit after rising revenue was offset by an increase in selling and other administrative costs. Pre-tax profit for the year through...

UK stocks slumped on Monday as the Chinese death toll from a coronavirus outbreak rose to 81 and new cases were reported around the world, prompting fears over the economic impact on the travel and...

UK stocks slumped on Monday as the Chinese death toll from a coronavirus outbreak rose to 81 and new cases were reported around the world. At 13.10, the benchmark FTSE 100 index was down 159.4...

UK stocks slumped in early trade on Monday as the Chinese death toll from a coronavirus outbreak rose to 81 and new cases were reported around the world. At 0846, the benchmark FTSE 100 index was...

AstraZeneca said it had agreed to sell the global commercial rights to its hypertension drugs and also said it would recover rights from Allergen to a drug used to treat Crohn's disease. The...

AstraZeneca said its gastric cancer and stroke treatments had met their primary goal in clinical trials. Gastric cancer drug, Enhertu, met its primary endpoint of an improvement in objective...

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8810p (from 8300p). Story provided by StockMarketWire.com Broker Forecasts...

Pharmaceutical company AstraZeneca said its liver cancer treatment had received orphan drug designation from the US Food and Drug Administration. Imfinzi (durvalumab) and tremelimumab, an...

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8500p (from 8200p). Story provided by StockMarketWire.com Broker...

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8500p (from 8300p). Story provided by StockMarketWire.com Broker...

AstraZeneca and partner Merck said their application for a drug used to treat advanced ovarian cancer had been granted priority review in the US. The pharmaceutical company also said it had ended...

UK markets ended the Monday trading session firmly in the red on Monday as escalating political tensions between the US and Iran led investors to strap on their tin hats as oil and gold prices...

Morgan Stanley today reaffirms its equal weight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8100p (from 7400p). Story provided by StockMarketWire.com Broker...

UK stocks continued to tumble in midday trading on Monday as escalating political tensions between the US and Iran led investors to strap on their tin hats as oil prices spike. The controversial...

JP Morgan Cazenove today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8500p (from 7900p). Story provided by StockMarketWire.com Broker...

The FTSE 100 was down almost 1% in early trading this morning as tensions between Iran and the US hit new highs. The news overshadowed some positive updates from major companies. AstraZeneca's...

AstraZeneca said its drug to treat hyperkalaemia had been approved in China. The company's drug Lokelma - used to treat adult patients with elevated levels of potassium in the blood...

UK stocks fell on Monday after a dearth of economic, political and company news during traditionally quiet post-Christmas trading. It was a similar picture across the Atlantic, as the S&P 500...

UK stocks fell further by midday on Monday after a dearth of economic, political and company news during traditionally quiet post-Christmas trading. At 1155, the benchmark FTSE 100 index was down...

UK stocks opened weaker on Monday during traditionally quiet post-Christmas trading in what was an otherwise strong December for investors. At 0850, the benchmark FTSE 100 index was down 12.12...

AstraZeneca and partner Merck said a treatment for pancreatic cancer had been approved for use in the US. Lynparza had been permitted for the maintenance treatment of patients with deleterious...

UK stocks opened moderately lower on Friday following a two-week winning streak triggered by Boris Johnson's election win. At 0854, the benchmark FTSE 100 index was down 15.37 points, or 0.2%, at...

AstraZeneca said a triple combination therapy for the treatment of chronic obstructive pulmonary disease had been approved in China. The triple therapy comprised a budesonide, glycopyrronium and...

UK stocks pushed higher in early trade on Friday amid expectations that parliament would later in the day approve Boris Johnson's Brexit deal. At 0845, the benchmark FTSE 100 index was up 17.74...

AstraZeneca said it had agreed to sell the commercial rights to Arimidex and Casodex, used primarily to treat breast and prostate cancers, in a number of European, African and other countries to...

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8200p (from 7300p). Story provided by StockMarketWire.com Broker...

UK stocks continued their momentum throughout Monday to record the sharpest increase since the aftermath to the EU referendum vote. Buoyed by a 'Boris bounce' thanks to the lifting of political...

A 'shock' slowdown in UK output was not enough to dampen momentum in blue chip stocks on Monday. Activity among UK businesses declined at the fastest pace in 41 months, according to the latest PMI...

UK stocks made substantial gains on Monday after the US and China announced they had struck a 'phase one' trade agreement, while Prime Minister Boris Johnson vowed to acted swiftly progressing his...

AstraZeneca said it had agreed to sell the rights to its anti-psychotic drugs in Europe and Russia to Cheplapharm for up to $239m. The drug company previously sold the rights to its anti-psychotic...

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8400p (from 8300p). Story provided by StockMarketWire.com Broker Forecasts data...

AstraZeneca said that its drug to treat patients with non-small cell lung cancer had received marketing authorisation from China's National Medical Products Administration. The approval of the...

AstraZeneca and Daiichi Sankyo released positive data from the a trial of a treatment for breast cancer. The phase-two trial studied the effects of trastuzumab deruxtecan in patients with...

AstraZeneca said it had agreed to sell the commercial rights to its schizophrenia and bipolar disorder drugs in the US and Canada to Cheplapharm Arzneimittel for up to $41m. AstraZeneca would...

AstraZeneca said the US Food and Drug Administration had accepted a supplemental biologics license application and granted priority review for its drug to treat extensive-stage small cell lung...

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 8250p). Story provided by StockMarketWire.com Broker Forecasts...

Bryan Garnier today upgrades its investment rating on AstraZeneca PLC (LON:AZN) to buy (from neutral) and raised its price target to 7950p (from 7700p). Story provided by StockMarketWire.com...

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 8200p). Story provided by StockMarketWire.com Broker...

AstraZeneca said its drug to improve glucose levels in adults with type-2 diabetes had been approved by the European Commission. The approval was based on data from five phase III trials...

AstraZeneca and MSD said their application for a drug used to treat paediatric patients suffering from neurofibromatosis had been accepted by the US Food and Drug Administration and granted...

AstraZeneca said its lupus drug had shown superior results compared with a placebo in a clinical trial. On the primary endpoint, anifrolumab achieved meaningfully reduced disease activity at week...

UK stocks clawed back some of their earlier losses on Monday as a mix of political tensions in Hong Kong and weaker than expected growth in UK third-quarter Gross Domestic Product (GDP) weighed on...

UK stocks saw accelerated losses on Monday after a weak start in reaction to a violent escalation of political tensions in Hong Kong sent Asian exchanges lower. Adding pressure to stocks was weaker...

UK stocks opened weaker on Monday after a violent escalation of political tensions in Hong Kong sent Asian exchanges lower. At 0852, the benchmark FTSE 100 index was down 38.41 points, or 0.5%,...

AstraZeneca said pooled analyses had shown that its drug used to treat patients with anaemia from chronic kidney disease had met its primary goal with no increased cardiovascular risk. The pooled...

AstraZeneca said results from clinical trials showed that a drug to treat patients with anaemia from chronic kidney disease had significantly increased red haemoglobin levels. The so-called...

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 7800p). Story provided by StockMarketWire.com Broker Forecasts data...

AstraZeneca said it had agreed to sell and licence the commercial rights to its schizophrenia and bipolar drugs in Europe and Russia to Cheplapharm. Seroquel and Seroquel XR used primarily to...

Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8000p (from 7700p). Story provided by StockMarketWire.com Broker Forecasts...

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5800p (from 5700p). Story provided by StockMarketWire.com Broker Forecasts data provided...

Liberum Capital today upgrades its investment rating on AstraZeneca PLC (LON:AZN) to buy (from hold). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

The FTSE 100 ended the day towards its highs despite continued government wrangling over the prime minister's withdrawal bill agreement and election rumours swirling around Westminster. The FTSE...

The FTSE 100 traded higher on Thursday as the government continued to wrangle over the prime minister's withdrawal bill agreement. The ongoing uncertainty failed to dent UK shares, and at midday...

The FTSE 100 has opened higher as the UK government continues to wrangle over the prime minister's withdrawal bill agreement. The ongoing uncertainty has failed to dent UK shares, and at 8.58am...

AstraZeneca upgraded its guidance on product sales following a 16% rise in the third quarter of the year, led by growth in its portfolio of cancer drugs. Product sales at constant currency were...

UK stocks opened higher on Monday after Asian exchanges were lifted by hopes of progress in US-China trade talks, and a further delay on parliament's vote on Boris Johnson's Brexit deal pressured...

AstraZeneca said its type-2 diabetes drug was approved by US regulators to reduce the risk of hospitalisation for heart failure in adults with the condition and established cardiovascular disease....

Having surged in morning trading after prime minister Johnson and European Commission president Juncker said that the two sides had reached a 'fair agreement' on Brexit, UK stocks held onto most of...

UK stocks surged in midday trading after UK prime minister Johnson and European Commission president Juncker said that the two sides had reached a 'fair agreement' on Brexit. The pound rallied...

UK stocks remained largely flat in early trading as clarity was in short supply around the UK's negotiations with Brussels around securing a potential Brexit deal. The pound had slipped against...

AstraZeneca said the US Food and Drug Administration had granted the priority review for its metastatic breast cancer drug. The review date for the drug was set for the cancer drug, was set for...

Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6700p (from 6550p). Story provided by StockMarketWire.com Broker...

UK stocks rallied from Thursday's eight-month low heading into the weekend despite US employment data which missed estimates, fuelling concerns about the health of the world's biggest economy. At...

UK stocks rebounded from Thursday's eight-month low heading into the weekend although investors remained braced for the release of monthly US employment data later in the day, amid growing concerns...